Featured Product
This Week in Quality Digest Live
Health Care Features
Grant Ramaley
FDA seeks to align Part 820 with ISO 13485:2016; why that may not be enough.
Claudine Mangen
If you have the energy to try and address organizational overwork, start small
Gregory Way
Drug designers are rethinking their response to medications that affect multiple targets
Adam Zewe
Research on machine-learning models that can help doctors consult patient records more easily
Karina Montoya
Analysis of social and economic impact bolsters the fight against hepatitis C

More Features

Health Care News
Making the new material freely available to testing laboratories and manufacturers worldwide
Google Docs collaboration, more efficient management of quality deviations
MIT course focuses on the impact of increased longevity on systems and markets
Delivers time, cost, and efficiency savings while streamlining compliance activity
First responders may benefit from NIST contest to reward high-quality incident command dashboards
Enhances clinical data management for medtech companies
Winter 2022 release of Reliance QMS focuses on usability, mobility, and actionable insights
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus
First Responder UAS Triple Challenge focuses on using optical sensors and data analysis to improve image detection and location

More News


CBI’s default image

Health Care

‘Product Recalls Series’ Returns to Indy

Second annual event brings together key stakeholders

Published: Wednesday, March 27, 2013 - 12:34

(CBI: Woburn, MA) -- For the past eight years, CBI’s Product Recalls Series has led the way in providing key updates and best practices for successful execution of drug, device, and diagnostic recalls corrections.

CBI’s Annual Product Recalls Summit, being held in Indianapolis on June 11–12, 2013, will unite all stakeholder voices, including manufacturer, regulatory, hospital, wholesaler, and distributor, to help increase compliance and efficiency when encountering a recall- or field-correction situation.

Register now!

At the summit, you will hear industry case studies and featured topics, including:
• Current state of recalls and assessment of FDA expectations
• Industry approaches and best practices for drug and device recalls
• Global regulatory landscape and the impact of varying international expectations
• Communication strategies for effectively disseminating recall information
• How to train cross-functional business teams on effective execution of product recalls

Distinguished speakers include Cecilia Wolyniak, recall team leader at the Office of Enforcement, Division of Compliance Management and Operations, at the Food & Drug Administration (FDA); and James Tillman, RAC, vice president of Quality and Regulatory Compliance Initiatives at Danaher Corp.

Learn more and register here.


About The Author

CBI’s default image


CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device, and health care industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators. Visit online at www.cbinet.com